DE3565102D1 - 1,3-disubstituted piperidine compounds as neuroleptic agents - Google Patents

1,3-disubstituted piperidine compounds as neuroleptic agents

Info

Publication number
DE3565102D1
DE3565102D1 DE8585305079T DE3565102T DE3565102D1 DE 3565102 D1 DE3565102 D1 DE 3565102D1 DE 8585305079 T DE8585305079 T DE 8585305079T DE 3565102 T DE3565102 T DE 3565102T DE 3565102 D1 DE3565102 D1 DE 3565102D1
Authority
DE
Germany
Prior art keywords
piperidine compounds
neuroleptic agents
useful
formula
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585305079T
Other languages
German (de)
English (en)
Inventor
Reinhard Sarges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE3565102D1 publication Critical patent/DE3565102D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585305079T 1984-07-26 1985-07-17 1,3-disubstituted piperidine compounds as neuroleptic agents Expired DE3565102D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/634,910 US4593037A (en) 1984-07-26 1984-07-26 1,3-disubstituted piperidine compounds as neuroleptic agents

Publications (1)

Publication Number Publication Date
DE3565102D1 true DE3565102D1 (en) 1988-10-27

Family

ID=24545655

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585305079T Expired DE3565102D1 (en) 1984-07-26 1985-07-17 1,3-disubstituted piperidine compounds as neuroleptic agents

Country Status (8)

Country Link
US (1) US4593037A (enExample)
EP (1) EP0175452B1 (enExample)
JP (1) JPS6137768A (enExample)
AT (1) ATE37358T1 (enExample)
DE (1) DE3565102D1 (enExample)
DK (1) DK167974B1 (enExample)
GR (1) GR851811B (enExample)
IE (1) IE58121B1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299549A3 (en) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
HU207310B (en) * 1988-12-02 1993-03-29 Pfizer Process for producing aryl-piperidine derivatives
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
US5459151A (en) * 1993-04-30 1995-10-17 American Home Products Corporation N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
US5457207A (en) * 1993-10-05 1995-10-10 Regents Of The University Of Minnesota Spirovesamicols
DE102004036349A1 (de) * 2004-07-27 2006-03-23 Grünenthal GmbH Substituierte 3-Phenylpiperidin-Derivate
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB984119A (en) * 1960-06-20 1965-02-24 Aspro Nicholas Ltd Substituted piperidines and methods for their preparation
GB1044309A (en) * 1964-05-07 1966-09-28 Koninklijke Pharma Fab Nv Substituted 1-aralklyl-piperidines
FR2310762A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives n-substitues de la phenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4332942A (en) * 1977-09-13 1982-06-01 Pfizer, Inc. 3-(2-Hydroxy-4-(substituted)phenyl)azacycloalkanes as analgesics
PT72172B (en) * 1979-12-05 1982-07-05 Astra Laekemedel Ab Process for preparing new phenyl-azacycloalkanes

Also Published As

Publication number Publication date
JPH0533696B2 (enExample) 1993-05-20
ATE37358T1 (de) 1988-10-15
IE58121B1 (en) 1993-07-14
DK338985D0 (da) 1985-07-25
EP0175452A1 (en) 1986-03-26
DK338985A (da) 1986-03-13
GR851811B (enExample) 1985-11-26
EP0175452B1 (en) 1988-09-21
IE851857L (en) 1986-01-26
JPS6137768A (ja) 1986-02-22
US4593037A (en) 1986-06-03
DK167974B1 (da) 1994-01-10

Similar Documents

Publication Publication Date Title
KR900700486A (ko) 신규한 벤조피리도 피페리딘, 피페리딜리덴 및 피페라진 화합물, 조성물, 제조방법 및 이용방법
ATE65500T1 (de) Arylthioalkylphenylcarbonsaeuren, diese enthaltende zusammensetzungen und deren verwendung.
DE69216293D1 (de) 1,4-Disubstituierte Piperidinderivate, ihre Herstellung und therapeutische Verwendung
DE3587777D1 (de) Heterozyklische Verbindungen, deren Herstellung und Medikamente diese enthaltend.
GR851811B (enExample)
ATE138663T1 (de) Oxothiolane und derivate, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als arzneimittel
ATE79622T1 (de) 1,4-diazepine.
FI852806L (fi) 2-substituerade -1,3-propylidendifosfonatderivat och deras framstaellning.
OA07582A (fr) Dérivés de la pipéridinedione protecteurs du myocarde présentant une activité antiarythmique, leur procédé de préparation et les médicaments qui contiennent lesdits dérivés.
SE8500107D0 (sv) Neue 8alfa-acylaminoergoline
ATE62908T1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
DE69005984D1 (de) 2-Hydroxy-3-phenoxypropylaminoverbindungen.
ATE111899T1 (de) 1,2,3,4-tetrahydro-1,9-acridindiamine, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DK74085D0 (da) Isoxazolderivater, fremgangsmaade til deres fremstilling og laegemidlerindeholdende disse forbindelser
ATE14424T1 (de) Imidazolidin-derivate, verfahren zu deren herstellung und therapeutische anwendung.
DE68902386D1 (de) N-pyridinyl-9h-carbazol-9-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DE3876711D1 (de) Piperidin-derivate, deren herstellung und deren verwendung als heilmittel.
DE3770321D1 (de) 1,5-benzothiazepinderivate, deren herstellung und deren verwendung in der therapie.
MXPA03011193A (es) Nuevos compuestos utiles en enfermedad de reflujo.
IT1247697B (it) Composizioni farmaceutiche comprendenti 3-ammino-e-caprolattami per il potenziamento dei processi di apprendimento e della memoria.
Bell et al. Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides
LTIP1813A (en) Process for the preparation of 5-halogen-thienoisothiazol-3(2h)-on-1,1-dioxide containing basic substituents
SE8801798L (sv) Chemical intermediates and process
ATE17485T1 (de) 3,7a-diazacyclohepta(j,k)fluorenderivate, ihre herstellung und ihre therapeutische verwendung.
ATE12238T1 (de) Neue ketale von 3'''-dehydro-cardenolidtridigitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee